International Ophthalmology

, Volume 29, Issue 3, pp 187–190

Paroxysmal nocturnal hemoglobinuria may cause retinal vascular occlusions

  • Alexander F. Scheuerle
  • Nermin Serbecic
  • Sven C. Beutelspacher
Case Report


Background Paroxysmal nocturnal hemoglobinuria (PNH) is characterized by the classic triad of haemolytic anaemia, thrombophilia and cytopenia with the majority of cases occurring in adulthood. PNH constitutes a nonmalignant clonal disease of hematopoietic stem cells harboring somatic mutations in the X-linked phosphatidyl inositol glycan complementation group-A (PIG-A) gene. Methods We report for the first time retinal venous vascular occlusion as the primary manifestation of PNH. A patient of untypical age for retinal vascular occlusions presented with a history of 4 weeks of progressive reduction in visual acuity. Results The screening tests for thrombophilia were not successful. However, elevated LDH was detected, leading to the diagnosis of PNH. Conclusions To date, no report shows retinal vascular occlusion as the primary symptom leading to the diagnosis PNH. This article describes, for the first time, that this rare disease needs to be considered in the differential diagnosis of retinal vascular occlusions.


Retinal occlusion PNH Thrombosis 


  1. 1.
    Hauser D, Barzilai N, Zalish M, Oliver M, Pollack A (1996) Bilateral papilledema with retinal hemorrhages in association with cerebral venous sinus thrombosis and paroxysmal nocturnal hemoglobinuria. Am J Ophthalmol 1224:592–593Google Scholar
  2. 2.
    Dacie JV, Lewis SM (1972) Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol 53:3–23Google Scholar
  3. 3.
    Dinesh D, Baker B, Carter JM (2006) Cardiopulmonary bypass surgery in a patient with paroxysmal nocturnal haemoglobinuria. Transfus Med 163:206–208CrossRefGoogle Scholar
  4. 4.
    Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, Rosse W, Socie G (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 10612:3699–3709CrossRefGoogle Scholar
  5. 5.
    Song MH, Roh YJ (2007) Bilateral serous retinal detachment as the first manifestation of paroxysmal nocturnal haemoglobinuria. Eye 213:437–439CrossRefGoogle Scholar
  6. 6.
    Fukumoto JS, Gotlib J (2006) A patient with paroxysmal nocturnal hemoglobinuria, T cell large granular lymphocyte clonal expansion, and monoclonal gammopathy of undetermined significance. Am J Hematol 8111:870–874CrossRefGoogle Scholar
  7. 7.
    Olteanu H, Karandikar NJ, McKenna RW, Xu Y (2006) Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol 1265:781–788CrossRefGoogle Scholar
  8. 8.
    Ruiz-Arguelles A, Llorente L (2007) The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev 63:155–161CrossRefGoogle Scholar
  9. 9.
    Liebman HA, Feinstein DI (2003) Thrombosis in patients with paroxysmal noctural hemoglobinuria is associated with markedly elevated plasma levels of leukocyte-derived tissue factor. Thromb Res 1114–5:235–238CrossRefGoogle Scholar
  10. 10.
    Hegenbart U, Niederwieser D, Forman S, Holler E, Leiblein S, Johnston L, Ponisch W, Epner E, Witherspoon R, Blume K, Storb R (2003) Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal nocturnal hemoglobinuria. Biol Blood Marrow Transplant 911:689–697CrossRefGoogle Scholar
  11. 11.
    Kathula SK (2006) Eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 35526:2786; author reply 2787–2788CrossRefGoogle Scholar
  12. 12.
    Pride YB (2006) Eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 35526:2787; author reply 2787–2788Google Scholar
  13. 13.
    Singh J, Malani AK, Pabla M (2006) Eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 35526:2786; author reply 2787–2788Google Scholar
  14. 14.
    Takita M, Matsumura T, Kami M (2006) Eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 35526:2787; author reply 2787–2788Google Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Alexander F. Scheuerle
    • 1
  • Nermin Serbecic
    • 2
  • Sven C. Beutelspacher
    • 1
  1. 1.University Eye Hospital HeidelbergHeidelbergGermany
  2. 2.SMZ-Ost, Department of OphthalmologyViennaAustria

Personalised recommendations